| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Cost of goods sold | ||||
| Gross Profit | ||||
| % of revenue | 83.2% | 82.3% | ||
| Operating expenses | ||||
| Research and Development Expense | ||||
| Selling, General and Administrative Expense | ||||
| Total operating expenses | ||||
| % of revenue | 215.9% | 222.6% | ||
| Loss from operations | ||||
| % of revenue | -132.7% | -140.3% | ||
| Other income (expense) | ||||
| Change in fair value of convertible notes payable | ||||
| Interest expense | ||||
| Other income (expense), net | ||||
| Total other expense, net | ||||
| Loss before provision for income tax | ||||
| Provision for income tax | ||||
| Net loss attributable to common stockholders | ||||
| Net loss per share attributable to common stockholders | ||||
| Basic (in dollars per share) | ||||
| Diluted (in dollars per share) |